Clinical trial
Observational Study to Evaluate the Clinical Safety After Introduction of the Fixed Dose Artemisinin-based Combination Therapy Eurartesim® (Dihydroartemisinin/Piperaquine [Dha/Pqp]) in Public Health Districts in Sub-Saharan Africa.
NCT02199951 is registered in ClinicalTrials.gov with INDEPTH Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study to Evaluate the Clinical Safety After Introduction of the Fixed Dose Artemisinin-based Combination Therapy Eurartesim® (Dihydroartemisinin/Piperaquine [Dha/Pqp]) in Public Health Districts in Sub-Saharan Africa.
- Lead sponsor
- INDEPTH Network
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- December 31, 2014
- Enrollment
- 10,000 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.